NPPA approves hike in prices of coronary stents
Monday, April 1, 2019, 5:30 PM
Drug price regulator NPPA has approved hike in prices of cardiac stents by 4.2% in-line with the wholesale price index (WPI) of the previous calendar year, as per an official statement. As per the new prices notified by the National Pharmaceutical Pricing Authority (NPPA), a bare metal stent (BMS) would now cost Rs 8,261, while the drug eluting stent (DES) will cost Rs 30,080.
Prices of 390 non-scheduled cancer medicines slashed by up to 87%: Govt
Friday, March 8, 2019, 8:51 PM
The maximum retail price of 390 non-scheduled cancer medicines have been reduced by up to 87 per cent, which would result in annual savings of around Rs 800 crore for the patients, the government said Friday. The National Pharmaceutical Pricing Authority (NPPA) on February 27 had brought 42 non-scheduled anti-cancer drugs under price control, capping trade margin at 30 percent.